311 related articles for article (PubMed ID: 6454934)
1. [Value of bone gammagraphy with Tc99-methyldiphosphonate (gamma G Tc99-MDP) in renal osteodystrophy].
Garciá Garciá M; Vallés Prats M; López Pedret J; Pons Creus JM; Botey Puig A; Herranz G-Romero R; Setoain Quinquer J; Revert Torrellas L
Rev Clin Esp; 1981 Apr; 161(1):31-5. PubMed ID: 6454934
[No Abstract] [Full Text] [Related]
2. [Bone scintigraphy with 99Tcm polyphosphate in uremic osteodystrophy].
Meneghello A; Bertoli M; Naso A; Casara D; Camposampiero A; Presacco D
Radiol Med; 1980 Oct; 66(10):760-1. PubMed ID: 6452654
[No Abstract] [Full Text] [Related]
3. Tumoral calcinosis-like metastatic calcification in a patient with renal osteodystrophy: CT and scintigraphic appearances.
Kobayashi H; Hosono M; Fujimoto R; Konishi J
Clin Nucl Med; 1995 Dec; 20(12):1112-4. PubMed ID: 8674312
[No Abstract] [Full Text] [Related]
4. [Radioisotope studies of the bones in renal osteodystrophy].
Przedlacki J
Pol Tyg Lek; 1987 May; 42(18):562-4. PubMed ID: 3306627
[No Abstract] [Full Text] [Related]
5. [Classification of bone scintigrams in hemodialysis patients].
Ishibashi K; Miyamae T
Kaku Igaku; 1985 Mar; 22(3):367-76. PubMed ID: 3160875
[No Abstract] [Full Text] [Related]
6. [Importance of bone scanning with Tc 99m in the supervision of hemodialysis patients with chronic renal failure (author's transl)].
Kessler M; Ferry JP; Naoun A; Robert J; Huriet C
Nephrologie; 1981; 2(4):171-5. PubMed ID: 7329502
[TBL] [Abstract][Full Text] [Related]
7. [Histological and scintigraphic correlations in the diagnosis of uremic osteodystrophy].
Neumair F; Huber W; Riegler P; Cabassa N
Radiol Med; 1980 Oct; 66(10):762-3. PubMed ID: 6452655
[No Abstract] [Full Text] [Related]
8. Effects of renal failure and metabolic diseases upon bone scanning in children.
Schümichen C
Ann Radiol (Paris); 1983; 26(6):498-504. PubMed ID: 6316830
[No Abstract] [Full Text] [Related]
9. [Bone scintigraphy in evaluation of the effect of renal transplantation in patients with renal osteodystrophy].
Seto K
Rinsho Hoshasen; 1989 Nov; 34(12):1433-6. PubMed ID: 2593286
[TBL] [Abstract][Full Text] [Related]
10. [Bone gammagraphy in the diagnosis of uremic renal osteodystrophy].
Marco Franco JE; Alarcón Zurita A; Peñafiel A; Pizá Buñola C; Morey Molina A; Bestard Palmer J; Mairata Bosch S; Dalmau Diana M
Rev Clin Esp; 1982 Mar; 164(5):329-32. PubMed ID: 7100549
[No Abstract] [Full Text] [Related]
11. Diphosphonates in the evaluation of metabolic bone disease.
Fogelman I; Smith ML
Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
[TBL] [Abstract][Full Text] [Related]
12. A trial of semiquantitative analysis of whole body bone scintigraphy in renal osteodystrophy.
Kida T; Narita S
Eur J Nucl Med; 1987; 13(1):36-40. PubMed ID: 3109916
[TBL] [Abstract][Full Text] [Related]
13. [Radionuclide studies in chronically hemodialyzed patients. Bone scintigraphy for the evaluation and control of renal osteopathy].
Dudczak R; Kletter K; Czembirek H; Derfler K; Marosi L; Salomonowitz E; Schmidt P; Wurzer G; Zazgornik J
Wien Klin Wochenschr; 1984 Apr; 96(9):326-32. PubMed ID: 6236616
[TBL] [Abstract][Full Text] [Related]
14. Recognition of renal osteodystrophy on bone imaging.
Eggleston DE; Bartold K; Abghari R
Clin Nucl Med; 1986 Aug; 11(8):543-4. PubMed ID: 3742909
[TBL] [Abstract][Full Text] [Related]
15. Common bone features in osteomalacia, secondary hyperparathyroidism, and renal osteodystrophy.
Verlooy H; De Roo M; Mortelmans L; Dequeker J
Clin Nucl Med; 1991 May; 16(5):372-4. PubMed ID: 2054996
[No Abstract] [Full Text] [Related]
16. [Clinico-scintigraphic studies of bone disease (renal osteodystrophy) in patients on chronic hemodialysis (preliminary report)].
Ionova D; Garcheva M; Simeonova A; Kiriakov Z
Vutr Boles; 1988; 27(2):107-12. PubMed ID: 2842966
[TBL] [Abstract][Full Text] [Related]
17. [The value of scintimetry compared with histomorphology, parathormone assay, densitometry and radiology in renal osteopathy (author's transl)].
Lingg G; Nebel G; Dorr S
Rofo; 1982 Jan; 136(1):9-13. PubMed ID: 6212415
[TBL] [Abstract][Full Text] [Related]
18. Pentavalent technetium-99m-dimercaptosuccinic acid scintigraphy in renal osteodystrophy.
Higuchi T; Hirano T; Inoue T; Aoki J; Ueki K; Wakamatsu R; Yano S; Naruse T; Endo K
J Nucl Med; 1998 Mar; 39(3):541-3. PubMed ID: 9529307
[TBL] [Abstract][Full Text] [Related]
19. Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function.
Nisbet AP; Edwards S; Lazarus CR; Malamitsi J; Maisey MN; Mashiter GD; Winn PJ
Br J Radiol; 1984 Aug; 57(680):677-80. PubMed ID: 6235885
[TBL] [Abstract][Full Text] [Related]
20. Amphotericin B therapy: a cause of increased renal uptake of Tc-99m MDP.
Trackler RT; Chinn RY
Clin Nucl Med; 1982 Jun; 7(6):293. PubMed ID: 6211323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
